Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

ÉN TIMES POSITIVT TRYKKVENTILASJON ETTER EN T-STYKKE SPONTAN ÅNDEDRETTSFORSØK: EN RANDOMISERT KLINISK STUDIE (GS-Wean Tpiece)

18. september 2026 oppdatert av: Hospital do Coracao

EITTIME POSITIV TRYKKVENTILASJON ETTER EIN T-STYKKE SPONTAN ÅNDEDRETSPRØVE: EIN RANDOMISERT KLINISK STUDIE

This is a randomized, open, multicenter, pragmatic, adaptive clinical trial with intention-to-treat analysis. The study will compare two weaning strategies from mechanical ventilation in critically ill patients admitted to intensive care units, with more than 72 hours of mechanical ventilation and with a successful spontaneous breathing trial on T-piece. Immediately after a successful spontaneous breathing trial, eligible patients will be randomized into 2 groups that will be treated according to one of the following interventions:

  1. One-hour positive pressure ventilation: as soon as the success of the spontaneous breathing trial is confirmed, the patient is submitted to mechanical ventilation for 1 hour using the previous ventilatory parameters and, afterwards, extubated.
  2. Immediate extubation: the patient is extubated immediately after the success of the spontaneous breathing trial.

Studieoversikt

Detaljert beskrivelse

Adaptive design for sample size. The study will include up to a maximum of 4.000 patients. First interim analysis will be performed after complete data is available for the first 500 eligible patients. The Bayesian logistic regression model will be adjusted to provide posterior probabilities that will be compared with threshold values to evaluate stopping decisions. Extensive simulations were conducted to develop and understand adaptive design performance, interim analysis timing, and decision criteria. The trial may be stopped early for efficacy or futility. Secondary outcomes will be analyzed with a gatekeeping procedure to preserve overall type I error at 0.05. Thus, the assessment of statistical significance of secondary outcomes will be performed only if the preceding outcome in the hierarchy met the threshold for statistical significance. No adjustment for multiple comparisons will be applied for analyses of tertiary outcomes and subgroups. Thus, these results should be interpreted as exploratory. Secondary outcomes tested in hierarchical order will be: (1) Mechanical ventilation free days within 28 days; (2) Hospital free days within 28 days; (3) Mortality within 28 days.

Studietype

Intervensjonell

Registrering (Antatt)

4000

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Patients aged > 18 years.
  • Admitted to the intensive care unit (surgical or medical).
  • With endotracheal intubation.
  • Mechanical ventilation for more than 72 hours.
  • Who underwent successful spontaneous breathing trial (according to the study protocol) and is considered able to be extubated.

Exclusion Criteria:

  • Patients unable to obey commands.
  • With non-planned extubation.
  • Neuromuscular disease and cervical spinal cord injury.
  • Tracheostomy.
  • Contraindication for cardiopulmonary resuscitation or reintubation.
  • Terminal extubation.
  • Lack of informed consent.
  • Previously included in the trial.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Forebygging
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: En-times positivt trykk ventilasjon

As soon as the success of the spontaneous breathing trial is confirmed, the patient is submitted to mechanical ventilation for 1 hour using the previous ventilatory parameters and, afterwards, extubated.

Aktiv komparator: Umiddelbar ekstubasjon

The patient is extubated immediately after the success of the spontaneous breathing trial.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Number of Participants With Extubation Failure Within 7 Days
Tidsramme: 7 days (from randomization through Day 7 after randomization)

Extubation failure is defined as a composite endpoint of reintubation or death within 7 days after randomization.

7 days (from randomization through Day 7 after randomization)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Ventilator-Free Days Through Day 28
Tidsramme: 28 days (from randomization through Day 28 after randomization)

Ventilator-free days are defined as the number of days alive and free from invasive mechanical ventilation from randomization through Day 28 after randomization. If a patient dies before day 28, the ventilator-free days will be counted as zero. If a patient is reintubated and returns to mechanical ventilation and later is extubated again and remains in unassisted breathing until day 28, the ventilator-free days will be counted from the end of the last period of assisted breathing until day 28. An invasive mechanical ventilation period of less than 24 hours for surgical purposes will count as 1 ventilator-free day. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from mechanical ventilation for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome.

28 days (from randomization through Day 28 after randomization)
Hospital-Free Days Through Day 28
Tidsramme: 28 days (from randomization through Day 28 after randomization)

Hospital-free days are defined as the number of days alive and out of the hospital from randomization through Day 28 after randomization. If a patient dies before day 28, the hospital-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered alive and free from hospital for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed through day 28 to ascertain this outcome.

28 days (from randomization through Day 28 after randomization)
Number of Participants Who Died Within 28 Days
Tidsramme: 28 days (from randomization through Day 28 after randomization)

All-cause mortality from randomization through day 28

28 days (from randomization through Day 28 after randomization)

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Ventilatory Support-Free Days Through Day 28
Tidsramme: 28 days (from randomization through Day 28 after randomization)

Ventilatory support-free days are defined as the number of days alive and free from any ventilatory support (invasive or noninvasive) from randomization through day 28. Any use of invasive mechanical ventilation for any duration during a calendar day will count as 1 day with ventilatory support (i.e., not free). Use of noninvasive ventilatory support (noninvasive ventilation or high-flow nasal cannula) for ≥6 hours in any calendar day will count as 1 day with ventilatory support. Participants who die before day 28 will be assigned 0 ventilatory support-free days. If reintubation occurs and the participant later achieves unassisted spontaneous breathing again, ventilatory support-free days will be counted from the end of the last assisted-breathing period through day 28, provided the participant remains alive and free from ventilatory support.

28 days (from randomization through Day 28 after randomization)
Number of Participants With Extubation Failure Within 2 Days
Tidsramme: 2 days (from randomization through Day 2 after randomization)

Extubation failure is defined as a composite endpoint of reintubation or death within 2 days after randomization

2 days (from randomization through Day 2 after randomization)
Number of Participants With Death or Reintubation Within 28 Days
Tidsramme: 28 days (from randomization through Day 28 after randomization)

Composite endpoint of reintubation or death within 28 days after randomization

28 days (from randomization through Day 28 after randomization)
Intensive Care Unit-Free Days Through Day 28
Tidsramme: 28 days (from randomization through Day 28 after randomization)

ICU-free days are defined as the number of days alive and out of the intensive care unit from randomization through day 28. If a patient dies before day 28, the ICU-free days will be counted as zero. Patients discharged from the hospital in unassisted breathing before 28 days will be considered as alive and free from ICU for the remaining days up to 28 days. Patients transferred to another hospital or healthcare unit will be followed up until day 28 to assess this outcome.

28 days (from randomization through Day 28 after randomization)
Number of Participants Who Died in the Intensive Care Unit
Tidsramme: From randomization to ICU discharge, up to 90 days

All-cause mortality occurring from randomization until ICU discharge (death before ICU discharge).

From randomization to ICU discharge, up to 90 days
Number of Participants Who Died in the Hospital
Tidsramme: From randomization to hospital discharge, up to 90 days

All-cause mortality occurring from randomization until hospital discharge (death before hospital discharge)

From randomization to hospital discharge, up to 90 days

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. januar 2027

Primær fullføring (Antatt)

1. desember 2029

Studiet fullført (Antatt)

1. februar 2030

Datoer for studieregistrering

Først innsendt

23. desember 2025

Først innsendt som oppfylte QC-kriteriene

23. desember 2025

Først lagt ut (Faktiske)

7. januar 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

22. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

18. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere